Literature DB >> 18958502

Renin-angiotensin system-growth factor cross-talk: a novel mechanism for ureteric bud morphogenesis.

Ihor V Yosypiv1.   

Abstract

The renin-angiotensin system (RAS) plays a critical role in kidney development. Mutations in the genes encoding components of the RAS cause a spectrum of congenital abnormalities of the kidney and renal collecting system, ranging from hypoplasia of the renal medulla and hydronephrosis in mice to renal tubular dysgenesis in humans. However, the mechanisms by which an intact RAS controls proper renal system development and how aberrations in the RAS result in abnormal kidney and renal collecting system development are poorly understood. The renal collecting system originates from the ureteric bud (UB). A number of transcription and growth factors regulate UB branching morphogenesis to ultimately form the ureter, pelvis, calyces, medullary, and cortical collecting ducts. Importantly, UB morphogenesis is a key developmental process that controls organogenesis of the entire metanephros. This review emphasizes emerging insights into the role for the RAS in UB morphogenesis and explores the mechanisms whereby RAS regulates this important process. A conceptual framework derived from recent work indicates that cooperation between the angiotensin II AT(1) receptor and receptor tyrosine kinase signaling performs essential functions during renal collecting system development via control of UB branching morphogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18958502      PMCID: PMC2716751          DOI: 10.1007/s00467-008-1021-9

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  74 in total

1.  The angiotensin II AT2 receptor is an AT1 receptor antagonist.

Authors:  S AbdAlla; H Lother; A M Abdel-tawab; U Quitterer
Journal:  J Biol Chem       Date:  2001-08-15       Impact factor: 5.157

2.  Apoptosis induced by vitamin A signaling is crucial for connecting the ureters to the bladder.

Authors:  Ekatherina Batourina; Sheaumei Tsai; Sarah Lambert; Preston Sprenkle; Renata Viana; Sonia Dutta; Terry Hensle; Fengwei Wang; Karen Niederreither; Andrew P McMahon; Thomas J Carroll; Cathy L Mendelsohn
Journal:  Nat Genet       Date:  2005-09-25       Impact factor: 38.330

3.  An in vitro tubulogenesis system using cell lines derived from the embryonic kidney shows dependence on multiple soluble growth factors.

Authors:  H Sakurai; E J Barros; T Tsukamoto; J Barasch; S K Nigam
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

4.  Immunohistochemical localization of the epidermal growth factor, transforming growth factor alpha, and their receptor in the human mesonephros and metanephros.

Authors:  N Bernardini; F Bianchi; M Lupetti; A Dolfi
Journal:  Dev Dyn       Date:  1996-07       Impact factor: 3.780

5.  IGF-I treatment attenuates renal abnormalities induced by neonatal ACE inhibition.

Authors:  A B Nilsson; N Nitescu; Y Chen; G S Guron; N Marcussen; G L Matejka; P Friberg
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-09       Impact factor: 3.619

6.  Angiotensin type II receptor expression and ureteral budding.

Authors:  K Oshima; Y Miyazaki; J W Brock; M C Adams; I Ichikawa; J C Pope
Journal:  J Urol       Date:  2001-11       Impact factor: 7.450

7.  Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype.

Authors:  D W Threadgill; A A Dlugosz; L A Hansen; T Tennenbaum; U Lichti; D Yee; C LaMantia; T Mourton; K Herrup; R C Harris
Journal:  Science       Date:  1995-07-14       Impact factor: 47.728

8.  Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility.

Authors:  C R Esther; T E Howard; E M Marino; J M Goddard; M R Capecchi; K E Bernstein
Journal:  Lab Invest       Date:  1996-05       Impact factor: 5.662

9.  Wnt11 and Ret/Gdnf pathways cooperate in regulating ureteric branching during metanephric kidney development.

Authors:  Arindam Majumdar; Seppo Vainio; Andreas Kispert; Jill McMahon; Andrew P McMahon
Journal:  Development       Date:  2003-07       Impact factor: 6.868

10.  BMP receptor ALK3 controls collecting system development.

Authors:  Sunny Hartwig; Darren Bridgewater; Valeria Di Giovanni; Jason Cain; Yuji Mishina; Norman D Rosenblum
Journal:  J Am Soc Nephrol       Date:  2008-01       Impact factor: 10.121

View more
  7 in total

Review 1.  Local renin-angiotensin systems in the genitourinary tract.

Authors:  Craig Comiter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-11-13       Impact factor: 3.000

Review 2.  Wnt signaling and renal medulla formation.

Authors:  Jing Yu
Journal:  Pediatr Nephrol       Date:  2011-05-01       Impact factor: 3.714

3.  Activation of skin renin-angiotensin system in diabetic rats.

Authors:  Shao Yun Hao; Meng Ren; Chuan Yang; Diao Zhu Lin; Li Hong Chen; Ping Zhu; Hua Cheng; Li Yan
Journal:  Endocrine       Date:  2011-04-12       Impact factor: 3.633

4.  Characterization of mesonephric development and regeneration using transgenic zebrafish.

Authors:  Weibin Zhou; Rudrick C Boucher; Frank Bollig; Christoph Englert; Friedhelm Hildebrandt
Journal:  Am J Physiol Renal Physiol       Date:  2010-09-01

Review 5.  Genetics of congenital anomalies of the kidney and urinary tract.

Authors:  Renfang Song; Ihor V Yosypiv
Journal:  Pediatr Nephrol       Date:  2010-08-27       Impact factor: 3.714

6.  Cyst formation in the PKD2 (1-703) transgenic rat precedes deregulation of proliferation-related pathways.

Authors:  Panayiota Koupepidou; Kyriacos N Felekkis; Bettina Kränzlin; Carsten Sticht; Norbert Gretz; Constantinos Deltas
Journal:  BMC Nephrol       Date:  2010-09-02       Impact factor: 2.388

7.  Receptor tyrosine kinases in kidney development.

Authors:  Renfang Song; Samir S El-Dahr; Ihor V Yosypiv
Journal:  J Signal Transduct       Date:  2011-03-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.